Want to see TSE:ROMJ full AI Analyst Report?
ROMJ Stock Chart & Stats
C$0.59
>-C$0.01(-1.11%)
At close: 4:00 PM EDT
C$0.59
>-C$0.01(-1.11%)
Day’s Range― - ―
52-Week RangeC$0.37 - C$0.66
Previous CloseN/A
Volume86.21K
Average Volume (3M)114.03K
Market Cap
C$30.75M
Enterprise ValueC$46.33
Total Cash (Recent Filing)C$2.96M
Total Debt (Recent Filing)C$15.58M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Nov 18, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding67,578,920
10 Day Avg. Volume50,096
30 Day Avg. Volume114,033
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)0.71
Price to Sales (P/S)0.53
P/FCF Ratio-2.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$1.15Price Target Upside94.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)C$73.07M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRubicon has materially expanded revenue over several years, indicating growing commercial scale and demand for its branded cannabis portfolio. Continued top-line progression gives the company a larger base from which cultivation improvements, automation, and product mix changes can improve future earnings quality.
Premium Market Position And Brand StrengthLeadership in premium flower and recognition for a core brand support consumer differentiation in a regulated market where quality and brand identity influence repeat purchases. This positioning can help protect product mix and support distribution growth as the portfolio expands.
Cultivation Yield And Capacity UpsideHigher Pacifica yields provide evidence that cultivation and genetics improvements are translating into greater output from existing assets. The planned capacity expansion could support additional revenue without relying solely on new facilities, while improving the platform for operating leverage.
Bears Say
Severe Gross Margin CompressionThe sharp deterioration in gross margin shows that recent revenue growth has not translated into durable profitability. Cost pressures or unfavorable pricing and product mix are absorbing much of the sales benefit, leaving the company vulnerable if planned margin recovery takes longer.
Persistent Negative Cash GenerationNegative operating and free cash flow indicate that Rubicon is not yet consistently funding operations and investment internally. Continued cash consumption increases dependence on disciplined spending and external financing, limiting flexibility if growth initiatives or margin improvements are delayed.
Cascadia Ramp And Cost Execution RiskCascadia has not yet reached its targeted production efficiency, delaying the facility's expected contribution to volume and margins. Because the ramp requires further optimization, execution shortfalls could prolong start-up costs and postpone the benefits of added capacity.
Rubicon Organics News
ROMJ FAQ
What was Rubicon Organics Inc’s price range in the past 12 months?
Rubicon Organics Inc lowest stock price was C$0.37 and its highest was C$0.66 in the past 12 months.
What is Rubicon Organics Inc’s market cap?
Rubicon Organics Inc’s market cap is C$30.75M.
When is Rubicon Organics Inc’s upcoming earnings report date?
Rubicon Organics Inc’s upcoming earnings report date is Nov 18, 2026 which is in 59 days.
How were Rubicon Organics Inc’s earnings last quarter?
Rubicon Organics Inc released its earnings results on Aug 11, 2026. The company reported C$0.01 earnings per share for the quarter, beating the consensus estimate of -C$0.005 by C$0.015.
Is Rubicon Organics Inc overvalued?
According to Wall Street analysts Rubicon Organics Inc’s price is currently Undervalued.
Does Rubicon Organics Inc pay dividends?
Rubicon Organics Inc does not currently pay dividends.
What is Rubicon Organics Inc’s EPS estimate?
Rubicon Organics Inc’s EPS estimate is 0.01.
How many shares outstanding does Rubicon Organics Inc have?
Rubicon Organics Inc has 67,578,920 shares outstanding.
What happened to Rubicon Organics Inc’s price movement after its last earnings report?
Rubicon Organics Inc reported an EPS of C$0.01 in its last earnings report, beating expectations of -C$0.005. Following the earnings report the stock price went up 2.041%.
Which hedge fund is a major shareholder of Rubicon Organics Inc?
Currently, no hedge funds are holding shares in TSE:ROMJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rubicon Organics Inc
Rubicon Organics Inc. cultivates, processes, and distributes organic cannabis products for both recreational and medicinal consumers across Canada. The company markets its organic cannabis through its proprietary labels as well as various licensed brands. Founded in 2015, Rubicon Organics Inc. maintains its headquarters in Vancouver, Canada.
ROMJ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated clear operational momentum (record revenue, 20% yield gains at Pacifica, Cascadia brought online and certified, market share gains, and margin improvement potential excluding Cascadia start-up costs) alongside typical early-stage scaling challenges (Cascadia yields below targets, modest Q2 Cascadia revenue, higher SG&A, slight YoY decline in adjusted EBITDA, and limited cash). Management offered a coherent plan (yield optimization, in-house extraction, automation, portfolio optimization, international expansion) and expects margin and EBITDA ramp in H2 2026 into 2027. Overall, positives (revenue growth, operational wins, brand strength, certifications) materially outweigh the near-term costs and execution risks.View all TSE:ROMJ earnings summariesROMJ Stock 12 Month Forecast
Average Price Target
C$1.15
▲(94.92% Upside)